Health Trials

Ejection Fraction

1

Review clinical trials related to Ejection Fraction. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Tapering Heart Failure Medication in Patients With Heart Failure With Recovered Ejection Fraction; Open Label Prospective Random Trial

Study start date is on Nov 27th 2024. A patient with an initial ejection fraction (EF) of less than 40%, whose follow-up shows an improvement to an EF of 50% or higher, along with the left ventricular end-diastolic diameter returning to the normal range and taking 3 more heart failure medication randomed to drug tapering group ( RAS blocker or beta blocker) or continuing medication group.

Participants needed: 150
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Chungnam National University HospitalUpdated: Mar 27, 2026Locations: 2
Eligibility criteria

initial echocardiogram ejection fraction less than 40% [+8]

under age 18 year [+6]

Read more